[HTML][HTML] Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer …
JL Sherwood, C Corcoran, H Brown, AD Sharpe… - PloS one, 2016 - journals.plos.org
… There are a number of DNA extraction options that can be used for ctDNA analysis from
plasma or serum (S3 Table). We chose to compare three methods, all specifically designed for …
plasma or serum (S3 Table). We chose to compare three methods, all specifically designed for …
Detection of rare mutations in CtDNA using next generation sequencing
X Lv, M Zhao, Y Yi, L Zhang, Y Guan, T Liu… - JoVE (Journal of …, 2017 - jove.com
… of ctDNA detection in the clinic, here we present a technique which enriches rare mutations
for sequencing, Enrich Rare Mutation … , however the application of ctDNA analyses is still not …
for sequencing, Enrich Rare Mutation … , however the application of ctDNA analyses is still not …
[HTML][HTML] Implementing ctDNA analysis in the clinic: challenges and opportunities in non-small cell lung cancer
E Gobbini, A Swalduz, M Giaj Levra, S Ortiz-Cuaran… - Cancers, 2020 - mdpi.com
… inhibitors administration on ctDNA-based mutation detection. ctDNA analysis has also been
… the tumor by the so-called blood tumor mutational burden (bTMB). bTMB has recently been …
… the tumor by the so-called blood tumor mutational burden (bTMB). bTMB has recently been …
[HTML][HTML] The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
F Passiglia, S Rizzo, M Di Maio, A Galvano… - Scientific reports, 2018 - nature.com
… work showed that ctDNA analysis is characterized … mutation detected both in liquid biopsy
and in tumor tissue), false positives (T790M mutation detected in liquid biopsy but not detected …
and in tumor tissue), false positives (T790M mutation detected in liquid biopsy but not detected …
Tumor‐associated DNA mutation detection in individuals undergoing colonoscopy
P Fleshner, GD Braunstein, G Ovsepyan… - Cancer …, 2018 - Wiley Online Library
… This is one emerging reason for false-positive results in ctDNA analysis, which is difficult to
… In conclusion, our ctDNA panel and methodology detected ctDNA in the plasma of 13.2% of …
… In conclusion, our ctDNA panel and methodology detected ctDNA in the plasma of 13.2% of …
[HTML][HTML] Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
… (17), making targeted mutation approaches to ctDNA analysis more complex compared with
… explanations for the relatively low rate of ctDNA mutation detection in this study. First, HCC …
… explanations for the relatively low rate of ctDNA mutation detection in this study. First, HCC …
Improving the performance of somatic mutation identification by recovering circulating tumor DNA mutations
Y Fu, C Jovelet, T Filleron, M Pedrero, N Motté… - Cancer research, 2016 - AACR
… ctDNA mutation detection workflow We introduce a method, cmDetect (ctDNA mutation
detection), for the systematic identification of ctDNA mutations by leveraging information from the …
detection), for the systematic identification of ctDNA mutations by leveraging information from the …
[HTML][HTML] Targeted mutation detection in breast cancer using MammaSeq™
NG Smith, R Gyanchandani, OS Shah, GT Gurda… - Breast Cancer …, 2019 - Springer
… More research is required to enhance the sensitivity and specificity of mutation detection
in ctDNA. We note that the 1% allele fraction cutoff we used in the ctDNA analysis is for …
in ctDNA. We note that the 1% allele fraction cutoff we used in the ctDNA analysis is for …
Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
… ctDNA analysis methods as well as biological and technical challenges, which need to be
resolved for the integration of ctDNA analysis … more sensitive at mutation detection. Prominent …
resolved for the integration of ctDNA analysis … more sensitive at mutation detection. Prominent …
[HTML][HTML] Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
V Villaflor, B Won, R Nagy, K Banks, RB Lanman… - Oncotarget, 2016 - ncbi.nlm.nih.gov
… Of the 90 patients submitted for ctDNA analysis as part of clinical care, 68 had provided …
report utilizing the same ctDNA assay of an EGFR T790M mutation detected at progression when …
report utilizing the same ctDNA assay of an EGFR T790M mutation detected at progression when …